Literature DB >> 28659677

Colorectal Cancer: Postoperative Follow-up and Surveillance.

Satyajit Godhi1, Ashok Godhi2, Ravishankar Bhat1, Sundeep Saluja3.   

Abstract

Follow-up and surveillance form an important aspect of care in patients with colorectal cancers (CRC). Most recurrences will occur within 2 years of surgery and 90% by 5 years. Follow up protocols have not been well defined in stage I disease and the approach should be individualized. As 40% of patients with stages II and III will develop recurrences, intensive postoperative follow-up strategy is recommended for them. It includes visit to the clinician for clinical examination, serum carcinoembryonic antigen (CEA), computed tomography (CT) of the chest and abdomen, colonoscopy, and flexible proctosigmoidoscopy in rectal cancers. Surveillance should be undertaken in those who are medically fit for repeat surgical procedures or for chemoradiotherapy. The concept of intensive post operative surveillance is based on the fact that some of these patients can have resectable/curable recurrence.

Entities:  

Keywords:  Colorectal cancer; Follow-up; Surveillance

Year:  2017        PMID: 28659677      PMCID: PMC5473799          DOI: 10.1007/s12262-017-1610-6

Source DB:  PubMed          Journal:  Indian J Surg        ISSN: 0973-9793            Impact factor:   0.656


  25 in total

Review 1.  Intensive follow-up strategies improve outcomes in nonmetastatic colorectal cancer patients after curative surgery: a systematic review and meta-analysis.

Authors:  S Pita-Fernández; M Alhayek-Aí; C González-Martín; B López-Calviño; T Seoane-Pillado; S Pértega-Díaz
Journal:  Ann Oncol       Date:  2014-11-19       Impact factor: 32.976

2.  Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients.

Authors:  D Schoemaker; R Black; L Giles; J Toouli
Journal:  Gastroenterology       Date:  1998-01       Impact factor: 22.682

3.  Usefulness of carcinoembryonic antigen monitoring despite normal preoperative values in node-positive colon cancer patients.

Authors:  Z Zeng; A M Cohen; C Urmacher
Journal:  Dis Colon Rectum       Date:  1993-11       Impact factor: 4.585

4.  Five-year follow-up after radical surgery for colorectal cancer. Results of a prospective randomized trial.

Authors:  J T Mäkelä; S O Laitinen; M I Kairaluoma
Journal:  Arch Surg       Date:  1995-10

5.  The role of postoperative colonoscopic surveillance after radical surgery for colorectal cancer: a prospective, randomized clinical study.

Authors:  Ting Wang; Yi Cui; Wen-Sheng Huang; Yan-Hong Deng; Wei Gong; Chu-Jun Li; Jian-Ping Wang
Journal:  Gastrointest Endosc       Date:  2009-01-10       Impact factor: 9.427

6.  The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer.

Authors:  J L McCall; R B Black; C A Rich; J R Harvey; R A Baker; J M Watts; J Toouli
Journal:  Dis Colon Rectum       Date:  1994-09       Impact factor: 4.585

7.  Postsurgical surveillance of colon cancer: preliminary cost analysis of physician examination, carcinoembryonic antigen testing, chest x-ray, and colonoscopy.

Authors:  R A Graham; S Wang; P J Catalano; D G Haller
Journal:  Ann Surg       Date:  1998-07       Impact factor: 12.969

8.  General practice vs surgical-based follow-up for patients with colon cancer: randomised controlled trial.

Authors:  D A Wattchow; D P Weller; A Esterman; L S Pilotto; K McGorm; Z Hammett; C Platell; C Silagy
Journal:  Br J Cancer       Date:  2006-04-24       Impact factor: 7.640

9.  Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial.

Authors:  John N Primrose; Rafael Perera; Alastair Gray; Peter Rose; Alice Fuller; Andrea Corkhill; Steve George; David Mant
Journal:  JAMA       Date:  2014-01-15       Impact factor: 56.272

Review 10.  Follow-up of patients with curatively resected colorectal cancer: a practice guideline.

Authors:  Alvaro Figueredo; R Bryan Rumble; Jean Maroun; Craig C Earle; Bernard Cummings; Robin McLeod; Lisa Zuraw; Caroline Zwaal
Journal:  BMC Cancer       Date:  2003-10-06       Impact factor: 4.430

View more
  3 in total

1.  Disparities in post-operative surveillance testing for metastatic recurrence among colorectal cancer survivors.

Authors:  Janeth I Sanchez; Veena Shankaran; Joseph M Unger; Margaret M Madeleine; Noah Espinoza; Beti Thompson
Journal:  J Cancer Surviv       Date:  2021-05-24       Impact factor: 4.442

Review 2.  Follow-Up Recommendations after Curative Resection of Well-Differentiated Neuroendocrine Tumours: Review of Current Evidence and Clinical Practice.

Authors:  Angela Lamarca; Hamish Clouston; Jorge Barriuso; Mairéad G McNamara; Melissa Frizziero; Was Mansoor; Richard A Hubner; Prakash Manoharan; Sarah O'Dwyer; Juan W Valle
Journal:  J Clin Med       Date:  2019-10-05       Impact factor: 4.241

Review 3.  Molecular Network of Colorectal Cancer and Current Therapeutic Options.

Authors:  Zhe Huang; Mingli Yang
Journal:  Front Oncol       Date:  2022-04-06       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.